Skip to content

IAS: Growth hormone improves CD4 cell count in patients with a poor response to HAART

IAS: Have we prematurely discarded triple NRTI regimens?

IAS: Circumcision prevents three out of four female-to-male HIV infections

IAS: AZT-related anaemia is rare, but may be less prevalent with fixed-dose combinations, meta-analysis shows

IAS: Routine HIV testing acceptable to most pregnant women in Zimbabwe

IAS: UN HIV envoy delivers call to action to Rio conference

IAS: Single dose nevirapine for mother doesn't lead to worse CD4 response to HAART

IAS: Hepatitis C treatment should last for 48 weeks in HIV co-infected patients, study shows

IAS: Atazanavir safe and effective during pregnancy